ArticleCell cycle (Georgetown, Tex.)2014

Activities of multiple cancer-related pathways are associated with BRAF mutation and predict the resistance to BRAF/MEK inhibitors in melanoma cells.

Dingxie Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.